1. Introduction
Hexavalent chromium (Cr(VI)) is extensively used in electroplating and other metal-finishing processes, and has consequently become a common contaminant in industrial wastewater and aquatic environments impacted by these activities [
1]. Because electroplating operations commonly employ fluorinated chromium-mist suppressants alongside chromium-based processes, wastewater and receiving waters are susceptible to simultaneous contamination by Cr(VI) and PFAS-derived surfactants or their substitutes, creating a realistic co-occurrence scenario in industrially impacted aquatic environments [
2,
3]. In addition, monitoring data indicate that environmentally relevant chromium burdens persist in surface waters, with regional surveys reporting chromium levels of 22–185 μg/L in certain areas of China [
4]. The U.S. Environmental Protection Agency (EPA) recommends dissolved Cr(VI) aquatic-life criteria of 16 µg/L for acute freshwater exposure and 11 µg/L for chronic freshwater exposure, with corresponding saltwater criteria of 1100 and 50 µg/L, respectively [
5]. The Canadian Council of Ministers of the Environment (CCME) has established more stringent long-term guidelines for Cr(VI), with values of 1.0 µg/L for freshwater life and 1.5 µg/L for marine life [
6]. Since PFOS was listed as a persistent organic pollutant under the Stockholm Convention in 2009, regulatory restrictions on PFOS have accelerated the search for alternative chromium-mist suppressants in the electroplating industry [
7]. One prominent substitute is 6:2 chlorinated polyfluoroether sulfonate (6:2 Cl-PFESA, F-53B), which is widely used in China as a chromium-mist suppressant to reduce occupational exposure during electroplating operations [
8,
9]. Consistent with this use pattern, F-53B has been repeatedly detected in riverine waters (1.9–40.2 ng/L) and electroplating effluents (43–112 μg/L) [
9,
10]. Taken together, these field and effluent data suggest that aquatic organisms in electroplating-impacted systems may face a substantial risk of co-exposure to Cr(VI) and F-53B.
Single-chemical evidence indicates that both F-53B and Cr(VI) can perturb early development and neurobehavior in fish. For F-53B, reported adverse outcomes include embryotoxicity, reproductive toxicity, and the disruption of thyroid hormone homeostasis [
8,
10,
11]. In zebrafish embryos exposed to F-53B at ng/L levels, abnormal retinal layering and related swimming deficits have been observed, accompanied by the downregulation of genes involved in retinoic acid (RA) signaling, lens formation, and retinal development, which is consistent with interference with RA-dependent visual-pathway maturation [
12]. Beyond ocular endpoints, F-53B exposure could impair neurodevelopment and suppress locomotor activity during critical developmental windows, with evidence linking hypoactivity to dopaminergic-system injury [
13]. Cr(VI) exposure, meanwhile, has been shown to impair somitogenesis and organogenesis in zebrafish embryos, producing severe malformations and acute lethality at higher concentrations [
14,
15]. Exposed embryos and hatched larvae could exhibit growth retardation and altered locomotor performance, including anxiety-like behavioral phenotypes [
14,
15]. However, evidence from single-compound exposure studies is insufficient to predict whether combined exposure will produce additive, antagonistic, or synergistic effects in sensitive developmental pathways.
In contrast, the joint toxic effects and underlying mechanisms of F-53B and Cr(VI) co-exposure in higher aquatic organisms have not yet been clearly elucidated. Evidence from mixture contexts suggests that co-occurring pollutants could produce non-additive outcomes through changes in bioavailability and redox homeostasis. For example, polystyrene microplastics can adsorb F-53B and heavy metals, modulating their bioaccumulation and enhancing inflammatory and oxidative stress responses in aquatic organisms [
16,
17,
18]. In addition, low-dose combinations of Cd and imidacloprid during early development elevate retinal apoptosis and induce antioxidant-defense genes, consistent with mixture-driven oxidative stress and impaired retinal development [
19]. In a microbial model, concurrent F-53B and Cr(VI) contamination damages
Pseudomonas aeruginosa biofilms more severely than either pollutant alone, compromising membranes and matrix and driving excessive intracellular ROS with compensatory antioxidant-enzyme responses [
20]. Collectively, these findings imply that mixtures containing F-53B and metals might disrupt redox balance and developmental processes in a non-additive manner. However, the consequences of F-53B/Cr(VI) co-exposure for vertebrate visual-system development and function have not yet been systematically investigated.
Therefore, in the present study, F-53B and Cr(VI) were selected as representative co-occurring contaminants in electroplating-impacted waters to investigate their combined developmental and visual toxicity in zebrafish under ecologically relevant exposure conditions. The effects of single and combined exposures on developmental toxicity, locomotor behavior, ocular morphology, retinal histopathology, and transcriptional responses of RA signaling- and vision-related genes were compared. This study was designed to determine whether co-exposure induces endpoint-dependent interactions and to provide experimental evidence relevant to the ecological risk assessment of realistic contaminant mixtures in electroplating-associated aquatic environments.
2. Materials and Methods
2.1. Reagents and Materials
F-53B (≥98%) was obtained from Shanghai Maikun Chemical Co., Ltd. (Shanghai, China), and Cr(VI) was supplied as potassium dichromate (K2Cr2O7, analytical grade, ≥98%; Macklin Biochemical Technology Co., Ltd., Shanghai, China). Dimethyl sulfoxide (DMSO, ≥99.9%) and the anesthetic MS-222 (≥98%) were purchased from Sigma-Aldrich (St. Louis, MO, USA). F-53B was dissolved in DMSO as a co-solvent. A concentrated F-53B stock solution (1000 mg/L) was prepared in DMSO, stored in the dark at 4 °C, and diluted in standard reconstituted water (SRW) on the day of use to obtain working solutions. The K2Cr2O7 stock solution was prepared directly in SRW and similarly diluted immediately before use. All exposure solutions were freshly prepared and completely renewed every 24 h to minimize concentration drift due to uptake or degradation.
2.2. Zebrafish Husbandry and Embryo Collection
Sexually mature zebrafish (Danio rerio, AB strain; 6–12 months old) were maintained in a recirculating, filtered system at a density of 10–15 fish per 3 L tank, under the following conditions: 28 ± 1 °C, pH 6.5–7.5, conductivity 150–550 μS/cm, and a 14 h light/10 h dark photoperiod. Fish were fed Artemia nauplii twice daily. The adult fish system was supplied with dechlorinated and filtered freshwater. For embryo rinsing, incubation, and exposure, SRW was freshly prepared using ultrapure water and analytical-grade salts. The SRW contained 63.0 mg/L NaHCO3, 5.5 mg/L KCl, 294.0 mg/L CaCl2·2H2O, and 123.3 mg/L MgSO4·7H2O. The pH was adjusted to 7.2–7.4 before use.
For spawning, females and males were placed in breeding tanks at a ratio of 1:2 and separated by a vertical divider at 17:00 on the day before mating, with the water level maintained below half the divider height. At 08:00 the following morning, the divider was removed and lights were turned on to induce spawning. Fertilized eggs were collected within 0.5 h, while unfertilized and dead eggs were removed. Embryos were gently rinsed with SRW to remove debris, and 2 h post-fertilization (hpf) was designated as the start of the exposure experiment. Cleaned embryos were transferred to pre-warmed (28 °C) SRW and incubated in a temperature-controlled chamber.
2.3. Exposure Protocols
For the main developmental toxicity experiment, exposure levels were selected based on environmentally relevant concentrations of F-53B and Cr(VI) and the results of preliminary tests [
4,
9,
10]. Exposure groups were established as follows: untreated control (SRW only), vehicle control (VC; SRW containing 0.01% DMSO), single-compound exposures FB-L (F-53B, 10 μg/L), FB-H (F-53B, 100 μg/L), Cr-L (Cr(VI), 10 μg/L), and Cr-H (Cr(VI), 100 μg/L), and matched co-exposures Mix-L (F-53B + Cr(VI), 10 + 10 μg/L) and Mix-H (F-53B + Cr(VI), 100 + 100 μg/L). In the group names, FB denotes F-53B, Cr denotes Cr(VI), and Mix denotes matched F-53B/Cr(VI) co-exposure; L and H indicate the low-dose (10 μg/L) and high-dose (100 μg/L) exposure levels, respectively. All exposure solutions and VC were adjusted to the same final DMSO concentration (0.01%). Because all treated groups contained 0.01% DMSO, VC was used as the primary comparator for treatment effects. Comparisons between the untreated control and VC are provided in
Table S1.
Zebrafish embryos/larvae were continuously exposed for 120 h in the corresponding SRW-based exposure solutions. For each group, 200 healthy embryos at 2 hpf were used in each of three independent biological replicates and exposed until 120 hpf. Developmental endpoints were assessed in 6-well plates, with ten embryos placed in each well containing 5 mL of exposure solution. The embryo density was controlled to avoid crowding and hypoxia. All exposure media, including F-53B, Cr(VI), mixture solutions, VC, and control media, were completely renewed every 24 h. All exposures were conducted at 28 ± 1 °C and the pH of the SRW-based exposure media was maintained at 7.2–7.4, and dead embryos were removed promptly to ensure data quality. Concentrations of F-53B and Cr(VI) in the exposure media were quantified during the experiment (
Table S2). Detailed analytical procedures are provided in the
Supplementary Materials (Text S1).
2.4. Developmental Toxicity
Embryos were monitored until 120 hpf, and survival, hatching, and malformations were recorded over time, with quantitative assessments at key time points. Hatching was evaluated primarily at 72 hpf, supplemented by daily observations. Unfertilized and dead eggs were excluded from the denominators so that rates reflected only individuals alive at each assessment. Death was defined as embryo coagulation or cessation of heartbeat confirmed by continuous microscopic observation. Malformations were scored based on visible criteria, including pericardial/yolk-sac edema, axial and tail curvature, and localized hemorrhage or generalized edema. Malformation rate was calculated as the number of malformed larvae divided by the number of surviving larvae. All observations were conducted at 28 ± 1 °C under uniform illumination and pH 6.5–7.5 and were completed before daily renewal of the exposure medium to minimize positional or microenvironmental bias.
To further evaluate growth and functional development, larvae were lightly anesthetized with MS-222 at 120 hpf, imaged under a calibrated microscope, and analyzed in ImageJ (version 1.53c; National Institutes of Health, Bethesda, MD, USA) for body length. At 24 hpf, spontaneous tail coiling was recorded as the number of tail flicks per embryo over a 1-minute period. At 72 hpf, heart rate was quantified as beats per minute.
2.5. Ocular Morphometry and Retinal Histology
At 120 hpf, twenty larvae per group were collected for external morphometric analysis, fixed in 10% neutral buffered formalin for 24 h, and imaged under a light microscope. Body and ocular morphometrics were quantified in ImageJ, including body length, head width, and horizontal and vertical eye diameters. The measurements of head width and horizontal and vertical eye diameters are illustrated in
Figure S1A [
21]. Body length was defined as the distance from the anterior edge of the head to the tip of the tail.
For retinal histological assessment, twelve larvae from each replicate were randomly selected. After euthanasia, eyes were dissected, fixed in 10% neutral buffered formalin for 24 h, dehydrated through a graded ethanol series, and embedded in paraffin. Serial sections (4 μm) were prepared, stained with hematoxylin and eosin (H&E) (Servicebio, Wuhan, China), and then examined under a light microscope. Retinal layer thicknesses, including the ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), and outer nuclear layer (ONL), together with total retinal thickness (GCL + IPL + INL + ONL), were measured using ImageJ. Lens thickness was measured separately, and the corresponding structures are shown in
Figure S1B.
2.6. Larval Light–Dark Assay
At 120 hpf, larvae with normal morphology, spontaneous motility, and no obvious malformations were subjected to a standardized light–dark–light locomotor assay using a ViewPoint zebrafish tracking system (ViewPoint, Lyon, France). Both minute-by-minute and phase-averaged swimming speeds were recorded. Prior to testing, individual larvae were transferred to 24-well plates, with one larva per well, and acclimated for 30 min under laboratory conditions. The stimulus sequence consisted of 0–10 min light (Light1), 10–20 min dark (Dark), and 20–30 min light (Light2). Temperature was maintained at 28 ± 1 °C, and mechanical and visual disturbances were minimized. For each treatment group, 24 larvae were analyzed using the same camera and detection parameters. Raw position data were collected at 1-minute intervals and used to calculate swimming speed.
2.7. Gene Expression Analysis
Gene expression analysis focused on functional pathways associated with ocular development and visual toxicity, including RA signaling, lens differentiation, retinal development, and phototransduction. Procedures for total RNA isolation, reverse transcription, and quantitative real-time PCR (qPCR) are described in detail in the
Supplementary Materials (Text S2).
β-Actin served as the internal reference gene.
The qPCR panel included genes related to RA metabolism and signaling, lens development, retinal development, and phototransduction. The gene symbols, full names, and functional categories of all target and reference genes are summarized in
Table 1. Primer sequences for these genes are provided in
Table S3.
2.8. Statistical Analysis
Statistical analyses were performed using IBM SPSS Statistics 20.0 (IBM Corp., Armonk, NY, USA). Data are presented as mean ± standard deviation (SD), and p < 0.05 was considered statistically significant. Normality and homogeneity of variance were assessed using the Shapiro–Wilk test and Levene’s test, respectively. When necessary, square-root or reciprocal transformation was applied before final analysis.
The untreated control was used to evaluate potential vehicle-related effects, whereas the main exposure analysis used the vehicle control (VC) as the primary comparator because all exposure groups contained 0.01% DMSO. Depending on data distribution and variance homogeneity, comparisons were performed using the Student’s
t-test, Welch’s
t-test, the Mann–Whitney U test, one-way ANOVA, Welch’s ANOVA, or the Kruskal–Wallis test, followed by appropriate post hoc tests. Effect sizes were reported as η
2 for ANOVA-family tests and ε
2 for Kruskal–Wallis tests. Detailed assumption checks, transformation decisions, statistical tests, post hoc results,
p values, and effect sizes are provided in
Table S4 (Supplementary Materials, SM2, Excel format). Sample size and replicate number were determined with reference to previous zebrafish developmental toxicity studies using comparable endpoints [
8,
12]. A sensitivity analysis was further performed using G*Power software (version 3.1.9.7; Heinrich Heine University Düsseldorf, Düsseldorf, Germany) to evaluate the detectable effect sizes of the present design. The minimum detectable effect size ranged from approximately
f = 0.341 to
f = 0.995, depending on the endpoint-specific sample size. Detailed results are provided in
Table S5 (SM2, Excel format).
4. Discussion
The present study compared the effects of F-53B and Cr(VI) alone and in combination on zebrafish early development across organismal, ocular, retinal, behavioral, and transcriptional endpoints. Overall, co-exposure did not simply amplify the toxicity of either compound. Instead, the mixture changed the toxicity profile in an endpoint-dependent manner. F-53B alone produced measurable but relatively selective effects, particularly on developmental and ocular morphometric endpoints and selected visual-system-related transcripts. Cr(VI) alone showed more prominent effects on hatching suppression, locomotor inhibition, retinal-layer thinning, and several RA- and ocular-development-related transcriptional responses. In contrast, F-53B/Cr(VI) co-exposure was more clearly associated with enhanced malformation, increased heart rate, and specific retinal or ocular alterations, while some Cr(VI)-dominant behavioral, retinal, and transcriptional responses were not further aggravated. These comparisons demonstrate that combined-exposure assessment provides information beyond single-compound testing by revealing endpoint shifts, attenuation of selected single-compound responses, and distinct toxicity patterns that would not be predicted from either compound alone.
For developmental toxicity, F-53B, Cr(VI), and their mixtures all produced measurable adverse developmental effects, but the single-exposure and co-exposure groups differed in the dominant endpoints affected. The observed deformities, including axial curvature, pericardial edema, hemorrhage or generalized edema, and occasional ocular defects, are consistent with previous reports for F-53B [
8,
22] and Cr(VI) [
23]. Hatching impairment was observed in several exposure groups, but it did not show a simple monotonic concentration–response pattern. This differs from the clearer adverse trends observed for mortality and malformation. Such a pattern is biologically plausible because hatching is a time-dependent developmental process regulated by chorion structure, hatching-enzyme activity, embryonic movement, and developmental timing. Cr(VI) has been associated with reduced hatching success through the inhibition of hatching enzymes or chorion damage [
23], whereas F-53B has been reported to delay chorion rupture at environmentally relevant concentrations, possibly through thyroid hormone dysregulation [
24,
25]. The chorion also acts as a protective barrier that permits water and gas exchange while restricting the entry of many xenobiotics, and chemicals with different physicochemical properties may interact with or penetrate the chorion to different extents [
26]. In addition, toxicants can delay hatching without necessarily producing proportional increases in mortality or malformation [
27]. Consistent with this complexity, the OECD Fish Embryo Test guideline treats hatching as an interpretive endpoint rather than an endpoint for LC
50 calculation [
28]. Therefore, the hatching results are best interpreted as evidence of developmental delay or chorion-related disturbance, rather than as a direct concentration-dependent ranking of overall toxicity.
Mortality and malformation further illustrate the difference between single exposure and co-exposure. Malformation was increased in all exposure groups, and the high-dose mixture showed the most pronounced malformation response among the reported pairwise comparisons. This suggests that combined exposure increased the likelihood of visible developmental abnormalities at the whole-organism level. In contrast, cumulative mortality was elevated across exposure groups, but the mixtures did not consistently exceed the corresponding single-compound exposures. Thus, the mixture enhanced some developmental outcomes, such as malformation, but did not produce a uniform increase in lethality. This distinction is important because it shows that F-53B/Cr(VI) co-exposure cannot be described by a simple toxicity hierarchy in which mixture exposure is always more severe than single exposure. The absence of a uniform synergistic pattern is also consistent with the current understanding of mixture toxicity. Recent zebrafish mixture studies have shown that combined exposures may produce synergistic, additive, or antagonistic outcomes depending on dose ratio, endpoint, developmental stage, and toxicological mode of action [
29,
30]. For example, Hu et al. reported antagonistic responses in several cadmium–pesticide mixtures in zebrafish larvae and suggested that differences in mode of action and mixture-induced changes in uptake or detoxification may contribute to non-additive effects [
29]. In the present study, the apparent less-than-additive or antagonism-like responses observed for selected endpoints may reflect endpoint-specific response ceilings, different developmental timing, selective loss of sensitive embryos before later endpoint assessment, or toxicokinetic interactions. Overall, the developmental data indicate that co-exposure shifted the pattern of toxicity rather than uniformly increasing all adverse outcomes.
The ocular and retinal findings also demonstrate that mixture exposure produced a toxicity pattern distinct from either single compound alone. External eye enlargement was observed in several exposure groups, with the X-axis eye diameter increased in FB-L and all high-dose exposure groups, whereas the Y-axis eye diameter increased mainly in FB-L and Mix-H. These findings suggest that F-53B and co-exposure contributed to external ocular enlargement, but the response was not simply dose-dependent across all treatments. Histological analysis further revealed layer-specific and group-dependent retinal effects, whereas no significant difference in lens thickness was detected. Cr(VI)-only exposure was associated with retinal thinning: Cr-H showed a thinner total retina than Mix-H, and Cr-L showed reduced IPL and INL thickness relative to Mix-H. In contrast, Mix-H uniquely showed significant ONL thickening relative to VC and differed from several single-exposure groups. Therefore, co-exposure did not simply aggravate Cr(VI)-associated retinal thinning. Instead, the mixture appeared to redirect retinal structural responses, particularly at the high dose.
Interpretation of ocular toxicity also benefits from distinguishing rare severe defects from more common sublethal alterations. In the present study, anophthalmia was observed only once in the Cr-L group (
Figure 1D), and was absent in the Cr-H and mixture groups. Given the rarity of this phenotype, this observation should be interpreted cautiously. Nevertheless, it is notable that
rx1 was significantly downregulated only in the Cr-L group relative to VC, whereas no significant
rx1 change was detected in the corresponding mixture groups. This single-exposure-specific response suggests that low-dose Cr(VI) may affect part of the early eye-field developmental program, while co-exposure did not reproduce this molecular pattern. This divergence is biologically plausible in light of the established role of the Rx family in optic vesicle morphogenesis. In teleosts,
rx3 mutants fail to form eyes because optic vesicle development is impaired, and reduced
rx1 and
rx2 expression in
rx3 mutants supports a hierarchical Rx regulatory program during eye morphogenesis [
31]. In zebrafish
chokh/rx3 mutants,
rx1 expression is weak and transient and is insufficient to support optic vesicle evagination [
32]. In addition,
rx1 has been implicated in retinal progenitor proliferation [
31]. Together, these observations support the interpretation that the Cr(VI)-related suppression of
rx1 may be associated with ocular developmental vulnerability under the Cr-L condition. The absence of significant
rx1 downregulation in the mixture groups may further suggest that co-exposure modified, rather than simply intensified, the Cr(VI)-associated molecular response.
The transcriptional results provide preliminary molecular context for the morphological and histological observations, although their explanatory strength is constrained by the sensitivity of the qPCR analysis. As noted in
Section 3.4, the qPCR endpoints were powered to detect only very large omnibus effects (
f ≈ 0.995;
Table S5). Therefore, non-significant results for several genes, including
pkcα,
rho,
mipa,
atoh7,
crybb, and
aldh1a2, cannot be taken as evidence that these genes were unaffected by exposure. Rather, they only indicate that no statistically reliable changes were detected under the current qPCR design; moderate or subtle transcriptional responses cannot be excluded.
Within this limitation, the significant transcriptional responses help distinguish endpoint-specific differences between single and combined exposures. Low-dose Cr(VI) significantly induced
cyp26a1 and
rdh1 relative to VC, while Mix-L significantly increased
rdh1 expression. At 100 μg/L,
rdh1 expression in the FB-H and Cr-H groups exceeded that in Mix-H, and Cr-L and Mix-L also showed higher
rdh1 expression than Mix-H. This pattern suggests that the high-dose mixture attenuated selected single-compound transcriptional responses rather than enhancing them. Because RA signaling is essential for ocular and retinal patterning [
33], and disturbed RA gradients are associated with abnormal retinal differentiation and architecture [
21,
34], these findings suggest a possible involvement of RA-related signaling in the retinal alterations observed here.
Lens- and phototransduction-related genes also showed gene-specific responses.
cryaa was significantly downregulated only in the Mix-L group relative to VC, indicating a mixture-associated response at the low dose. In contrast,
crygn2 was significantly reduced in Cr-H relative to both VC and Mix-L, suggesting a Cr(VI)-dominant lens-related response at the high dose. The downregulation of
crygn2 may be consistent with altered lens structural protein homeostasis [
35]. For phototransduction-related genes,
opn1sw was reduced in FB-L and Cr-L,
opn1lw was reduced in Mix-L and Cr-H, and
gnat1 differed between FB-H and both mixture groups. These results indicate that F-53B, Cr(VI), and the mixture affected overlapping but non-identical visual-system-related transcriptional endpoints.
The behavioral results provide a functional comparison between single exposure and co-exposure. Locomotor inhibition was mainly driven by Cr(VI), and the mixture did not exceed the impairment caused by Cr(VI) alone. Specifically, reduced swimming speed relative to VC was observed in Cr-L during the dark phase and in Cr-L and Cr-H during the second light phase, whereas the mixture groups did not show significant locomotor inhibition relative to VC. This pattern is consistent with reports that metal exposure disrupts light–dark locomotor activity [
23]. Cr(VI) has also been linked to reduced spontaneous swimming together with the inhibition of AChE activity, suggesting impaired neuromuscular transmission [
36]. In parallel, changes in cone- and phototransduction-related genes were observed:
opn1sw was reduced in FB-L and Cr-L,
opn1lw was reduced in Mix-L and Cr-H, and
gnat1 differed significantly between FB-H and both mixture groups. Taken together, these findings indicate that altered light-responsive behavior in exposed larvae may reflect both neural and visual-system disruption. Importantly, however, the behavioral endpoint remained primarily Cr(VI)-driven, despite mixture-specific changes in retinal structure and gene expression. This again shows that co-exposure did not produce uniform potentiation, but instead generated endpoint-specific divergence across biological levels.
Several limitations should be considered when interpreting these single-exposure and co-exposure comparisons. First, the exposure window was intentionally restricted to early development up to 5 dpf. This window is appropriate for detecting acute developmental, early ocular, behavioral, and transcriptional responses in zebrafish embryos and larvae, as demonstrated by the significant effects observed in several endpoints. However, this design does not address delayed juvenile, adult, or life-cycle outcomes. Therefore, longer-term studies are needed to determine whether the early effects observed here persist, recover, or progress during later development [
37]. Second, although the matched-concentration design allowed for direct comparisons between single and combined exposures, pharmacokinetic or toxicokinetic data were not obtained, and internal dosimetry was not measured. Therefore, the present study cannot determine whether co-exposure altered the absorption, distribution, metabolism, or elimination of F-53B or Cr(VI), nor can it rule out the possibility that interactions between the two compounds affected their toxicokinetic behavior and internal exposure levels. The reduced or divergent responses observed for selected mixture endpoints are therefore described as endpoint-dependent toxicological patterns rather than being attributed to a specific absorption-, distribution-, metabolism-, or elimination-related mechanism. Third, behavioral assessment was limited to locomotor responses in a light–dark paradigm. Inclusion of vision-specific functional tests would strengthen the causal link between retinal structure, phototransduction-related gene expression, and visual performance. Fourth, the gene expression analysis should be considered preliminary because the qPCR endpoints were based on three biological replicates per group. Although this design is commonly used for exploratory transcriptional assessment in zebrafish developmental toxicity studies, the G*Power-based sensitivity analysis indicated that only very large effects could be detected with adequate power for these endpoints. Future studies should therefore validate these transcriptional findings using larger sample sizes, time-resolved sampling, and complementary approaches such as protein-level analysis, spatial retinal markers, or transcriptomic profiling. Finally, the present study used two matched concentration levels selected to represent environmentally relevant exposure scenarios and was not designed to establish complete concentration–response surfaces or formal mixture-toxicity models. A broader concentration matrix, including lower, intermediate, and higher concentrations as well as equitoxic mixture designs, would be required to distinguish concentration addition, independent action, and true synergistic or antagonistic interactions more rigorously.
Future studies should extend exposure duration using juvenile, multi-week, or life-cycle designs to determine whether the early mixture effects observed here persist, intensify, or transition into chronic outcomes and adaptive remodeling. Particular attention should be given to molecular targets highlighted in the present study, including
rx1, especially under Cr-L exposure, other members of the Rx family such as
rx2 and
rx3, RA-related genes such as
cyp26a1 and
rdh1, and phototransduction markers such as
opn1sw, opn1lw, and
gnat1. Integrating transcript-level analysis with spatially resolved retinal endpoints, including layer-specific cell composition, apoptosis or proliferation indices, and photoreceptor integrity, would provide a more complete view of the mechanisms involved. In addition, vision-related functional assays, such as optokinetic or optomotor responses, contrast sensitivity, and electrophysiological measurements where feasible, would help clarify structure–function relationships under single and mixed exposure conditions. Importantly, biomonitoring data indicate that non-occupational human internal exposure to F-53B and chromium generally occurs at trace to low-μg/L range, but concentrations in highly exposed populations, especially in breast milk from contaminated settings, could reach tens of μg/L and occasionally approach or exceed 100 μg/L [
38,
39,
40,
41]. Thus, the nominal concentrations used here, 10 and 100 μg/L, encompass the upper range of environmentally relevant burdens in certain matrices and hotspot scenarios.